Bruker appoints Philip Ma to board; director Marc Kastner to retire at 2023 meeting

BRUKER CORP

Philip Ma appointed to board effective April 1, 2022, filling newly created Class II vacancy.
Marc Kastner will retire and not stand for re-election at 2023 annual meeting; continues serving until then.
Ma is CEO/founder of PrognomiQ, in which Bruker made $12M minority investment in February 2022.
Ma's background includes multiomics, life science tools, and biopharma; will serve as non-employee director.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marc Kastner

Director

BRKR · BRUKER CORP

Filed: March 16, 2022, 7:59 PM ET

Dr. Marc Kastner informed the Board of Directors (“Board”) of Bruker Corporation (the “Company”) of his decision to retire and not to stand for re-election as a Class II director when his current term expires at the Company’s 2023 Annual Meeting of Stockholders

Appointed

Philip Ma

Director

BRKR · BRUKER CORP

Effective: 2022-04-01
Filed: March 16, 2022, 7:59 PM ET

the Board approved an increase in the number of directors to expand the size of the Board by one director to a total of eleven directors, with such additional director assigned to Class II, and appointed Dr. Philip Ma to fill the newly created vacancy on the Board, effective as of April 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marc Kastner departed as Director at BRUKER CORP.

Action: retire and not stand for re-election
Role: Director

Exact text from the filing

Dr. Marc Kastner informed the Board of Directors (“Board”) of Bruker Corporation (the “Company”) of his decision to retire and not to stand for re-election as a Class II director when his current term expires at the Company’s 2023 Annual Meeting of Stockholders

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Philip Ma was appointed as Director at BRUKER CORP.

Action: appointed
Role: Director

Exact text from the filing

the Board approved an increase in the number of directors to expand the size of the Board by one director to a total of eleven directors, with such additional director assigned to Class II, and appointed Dr. Philip Ma to fill the newly created vacancy on the Board, effective as of April 1, 2022.

View on SEC.gov

BRUKER CORP filing history →

Source: SEC EDGAR

accession 0001193125-22-076869

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.